Log In
BCIQ
Print this Print this
 

Overa (OVA2)

  Manage Alerts
Collapse Summary General Information
Company Vermillion Inc.
DescriptionNext-generation in vitro diagnostic multivariate index (IVDMIA) test for ovarian cancer
Molecular Target
Mechanism of Action 
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentApproved
Standard IndicationCancer, Diagnostic
Indication DetailsDiagnose ovarian cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today